What is the recommended starting dose and titration schedule of trazodone for a geriatric patient?

Recommended Trazodone Dosing for Elderly Patients

For elderly patients, start trazodone at 25 mg daily at bedtime and increase gradually by 25-50 mg every 3-7 days as tolerated, with a typical maximum dose of 200-300 mg/day (lower than the standard adult maximum of 400 mg/day). 1

Starting Dose and Initial Titration

• Begin with 25 mg at bedtime in elderly or debilitated patients 2, 3
• The FDA-approved labeling recommends initiating at a low dose with gradual increases, noting that drowsiness may require administering the major portion of the daily dose at bedtime 1
• Research specifically in elderly depressed patients demonstrated that starting at 50 mg three times daily (150 mg total) was well-tolerated and more effective than 25 mg three times daily, though the lower starting dose remains the safer initial approach 3

Titration Schedule

• Increase by 25-50 mg every 3-4 days based on clinical response and tolerability 1
• The dose should be titrated slowly in geriatric patients, with careful monitoring for adverse effects 2
• Most elderly patients respond to doses between 150-300 mg/day, administered predominantly at bedtime 4, 5

Maximum Dosing

• The maximum dose for elderly outpatients should typically not exceed 300-400 mg/day, which is lower than the 600 mg/day maximum sometimes used in younger hospitalized patients 1, 5
• Clinical studies in elderly patients have shown maximum tolerated doses of 300-400 mg/day, with therapeutic efficacy often achieved at 150-300 mg/day 5

Administration Considerations

• Administer trazodone shortly after a meal or light snack to optimize absorption and reduce side effects 1
• Single nighttime dosing is preferred over divided doses, as it provides equal antidepressant efficacy with improved sleep and less daytime drowsiness, particularly during the first 1-2 weeks of treatment 4, 6
• Tablets can be swallowed whole or broken along the score line for half-tablet dosing 1

Critical Safety Considerations in the Elderly

Orthostatic Hypotension and Falls

• Trazodone significantly increases the risk of orthostatic hypotension, syncope, and falls in elderly patients, particularly those with hypertension 7
• Recent evidence shows trazodone users (≥75 years) had a 58.3% incidence of syncope/falls versus 21.2% in non-users, with greater systolic BP drops immediately after standing (23.8 vs 14.3 mmHg) 7
• Monitor blood pressure closely, especially during dose titration and in patients with cardiovascular disease 5, 7

Cardiovascular Effects

• While trazodone has lower anticholinergic effects than tricyclic antidepressants, it may cause orthostatic hypotension, arrhythmias, and QT prolongation 5, 8
• Use with particular caution in elderly patients with pre-existing cardiovascular disease 5

Common Adverse Effects

• Somnolence is the most common side effect, which can be managed by administering the dose at bedtime 4, 8
• Other frequent adverse effects include headache, dizziness, and dry mouth 8
• Blurred vision and sedation occur more frequently with trazodone than placebo 9

Clinical Context and Alternatives

When Trazodone May Be Appropriate

• Trazodone is frequently prescribed off-label for insomnia in elderly patients due to perceived better tolerability compared to benzodiazepines 2, 7
• However, clinical guidelines advise against using trazodone for chronic insomnia due to limited efficacy evidence and concerning adverse effect profile 2
• For depression with comorbid insomnia, trazodone at low doses (25-100 mg) may be used as adjunctive therapy with another antidepressant 2

Important Limitations

• The 2005 NIH State-of-Science Conference concluded there is no systematic evidence for trazodone's effectiveness in treating insomnia, and risks may outweigh benefits 2
• A systematic review found no differences in sleep efficiency between trazodone (50-150 mg) and placebo, with studies limited to very short durations 2
• The American Academy of Sleep Medicine suggests clinicians NOT use trazodone for sleep onset or maintenance insomnia based on 50 mg dose trials 2

Dose Adjustments for Drug Interactions

• Consider reducing the dose when coadministering with strong CYP3A4 inhibitors based on tolerability 1
• Consider increasing the dose when coadministering with strong CYP3A4 inducers based on therapeutic response 1

Discontinuation

• Gradually taper the dose rather than stopping abruptly to minimize withdrawal symptoms and discontinuation syndrome 1
• Adverse reactions may occur upon discontinuation, necessitating a slow taper whenever possible 1